| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/26/1997 | CN1145809A Medicine for prevention and treatment of deficient blood-reperfusion disturbance |
| 03/26/1997 | CN1145808A Human growth horomne agent for adults |
| 03/26/1997 | CN1145785A Medicine for treatment of malignant tumour and its prepn |
| 03/26/1997 | CN1034335C Extraction and purification of an anticoagulant principle from the south american leech haementeria ghilanii |
| 03/25/1997 | US5614649 Treatment of muscular disorders, substituted guanidines |
| 03/25/1997 | US5614618 Origin of replication complex genes |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614587 Collagen-based bioadhesive compositions |
| 03/25/1997 | US5614560 Method of preventing NMDA receptor-mediated neuronal damage |
| 03/25/1997 | US5614557 Method of controlling tumor growth rate |
| 03/25/1997 | US5614547 Small molecule inhibitors of rotamase enzyme |
| 03/25/1997 | US5614539 Urea compounds which are useful as platelet aggregation inhibitors |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614522 Retroviral protease inhibitors |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614507 Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia |
| 03/25/1997 | US5614499 Anticoagulants; treatment or prophylaxis of thrombosis |
| 03/25/1997 | US5614498 Oligopeptides, bronchdilators |
| 03/25/1997 | US5614497 Treatment of hypertension, cardiovascular disease and renal disease |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614494 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 03/25/1997 | US5614493 Administering in a zymogen form |
| 03/25/1997 | US5614492 Diabetes |
| 03/25/1997 | US5614491 Liquid preparations containing cyclosporin and process for preparing same |
| 03/25/1997 | US5614490 Administration of low dose hemoglobin to increase perfusion |
| 03/25/1997 | US5614489 Method and composition for treating the skin |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614487 Sustained release pharmaceutical composition |
| 03/25/1997 | US5614409 Production of IBDV VP2 in highly immunogenic form |
| 03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/25/1997 | US5614397 Method and compositions for modulating lifespan of hematolymphoid cells |
| 03/25/1997 | US5614379 Process for preparing anti-obesity protein |
| 03/25/1997 | US5614373 Tumor-specific antibodies and antigen |
| 03/25/1997 | US5614371 Ri fusion antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof |
| 03/25/1997 | US5614370 Assay to identify human C5a antagonists and agonists |
| 03/25/1997 | US5614369 Endotoxin binding and neutralizing protein and uses thereof |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614219 Oral administration form for peptide pharmaceutical substances, in particular insulin |
| 03/25/1997 | US5614198 Bowman-Birk Inhibitor compositions for treatment of inflammatory disease |
| 03/25/1997 | US5614192 T cell receptor peptides as therapeutics for immune-related disease |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614190 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 03/25/1997 | US5614189 Recombinantly produced lipases for therapeutical treatment |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | US5614185 Compositions containing reduced, microbially produced interleukin-2 (IL-2) |
| 03/25/1997 | US5614184 Recombinant human erythropoietin mutants and therapeutic methods employing them |
| 03/25/1997 | US5614183 Use of CSF-1 to treat bacterial infections |
| 03/25/1997 | CA2108120C Method of treating gastrointestinal ulcers with platelet derived growth factor |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010354A1 ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
| 03/20/1997 | WO1997010353A1 Production of lysosomal enzymes in plant-based expression systems |
| 03/20/1997 | WO1997010343A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/20/1997 | WO1997010338A1 Improved interleukin-6 receptor antagonist |
| 03/20/1997 | WO1997010335A1 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific t-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | WO1997010333A1 Novel proteins remarkably expressed in liver cancer, genes encoding the same, antibodies against the same, and method for detecting the expression of the same |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010264A1 Cyclic hexapeptide compounds |
| 03/20/1997 | WO1997010263A1 Actinomycin d analogues |
| 03/20/1997 | WO1997010262A1 Peptide derivatives |
| 03/20/1997 | WO1997010261A1 Peptide derivatives |
| 03/20/1997 | WO1997010259A1 Method of producing muramyl peptides |
| 03/20/1997 | WO1997010258A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 03/20/1997 | WO1997010254A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | WO1997010007A1 Cancer treatment |
| 03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | WO1997010004A1 Methods for treatment of interstitial cystitis |
| 03/20/1997 | WO1997010003A1 Methods and compositions comprising single chain recombinant antibodies |
| 03/20/1997 | WO1997010002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009997A1 Cystic fibrosis therapy |
| 03/20/1997 | WO1997009996A1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 03/20/1997 | WO1997009995A1 Method for reducing the severity of gastro-intestinal damage |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997009993A1 Method for analyzing isomers of enalapril and enalaprilat |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009973A2 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1997009960A1 Composition and method for treating diseased nails |
| 03/20/1997 | WO1997009885A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | WO1997006815A3 Aqueous rinsing solution for endoscopic operations |
| 03/20/1997 | WO1997003700A3 Gamma-interferon activity modulating agent |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
| 03/20/1997 | WO1996025498A3 Mpl ligand analogs |
| 03/20/1997 | DE19536593A1 Use of an interferon-beta, e.g., a deriv. of human interferon-beta |
| 03/20/1997 | DE19535853A1 Varianten des humanen rekombinanten Interferon-gamma (rhu-IFN-gamma) mit erhöhter thermischer Stabilität Variants of the human recombinant interferon-gamma (rhu-IFN-gamma) with increased thermal stability |
| 03/20/1997 | DE19535571A1 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten Pharmaceutical combination preparations and their use for the treatment of hemodialysis patients |
| 03/20/1997 | DE19534630A1 Monoclonal antibodies to epithelial mucin |
| 03/20/1997 | CA2356097A1 Peripherally active anti-hyperalgesic opiates |